Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Liu, Jin Long ^a   Gao, Wei ^b   Kang, Qing Min ^a   Zhang, Xue Jun ^a   Yang, Shu Guang ^a  

^a CHENGDE MEDICAL COLLEGE   (China)

^b The Chinese People's Liberation Army 264th Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN;

CANCER PROGNOSIS; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; DISEASE ASSOCIATION; ETHNICITY; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW;

HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; META-ANALYSIS AS TOPIC; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84880990385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071930     Document Type: Review

References (43)

1. Averbach AM, Jacquet P, (1996) Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 83: 726-733. doi:10.1002/bjs.1800830605. PubMed: 8696727.
2. Greene FL, Sobin LH, (2002) The TNM system: our language for cancer care. J Surg Oncol 80: 119-120. doi:10.1002/jso.10114. PubMed: 12115792.
3. Kolev Y, Uetake H, Takagi Y, Sugihara K, (2008) Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 15: 2336-2344. doi:10.1245/s10434-008-9955-5. PubMed: 18521687.
4. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, et al. (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8: 86-94. doi:10.1007/s10120-005-0320-0. PubMed: 15864715.
5. Oldenhuis CN, Oosting SF, Gietema JA, de Vries EG, (2008) Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer (Oxf, England: 199044:: 946-953.
6. Samuel T, Okada K, Hyer M, Welsh K, Zapata JM, et al. (2005) cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res 65: 210-218. PubMed: 15665297.
7. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, et al. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320. PubMed: 9850056.
8. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, et al. (2002) A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci U S A 99: 4349-4354. doi:10.1073/pnas.072586399. PubMed: 11917134.
9. Sah NK, Khan Z, Khan GJ, Bisen PS, (2006) Structural, functional and therapeutic biology of survivin. Cancer Lett 244: 164-171. doi:10.1016/j.canlet.2006.03.007. PubMed: 16621243.
10. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, et al. (2000) High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623. doi:10.1038/sj.onc.1203358. PubMed: 10698506.
11. Hattori M, Sakamoto H, Satoh K, Yamamoto T, (2001) DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 169: 155-164. doi:10.1016/S0304-3835(01)00499-2. PubMed: 11431104.
12. Li F, Altieri DC, (1999) Transcriptional analysis of human survivin gene expression. Biochem J 3442:: 305-311. doi:10.1042/0264-6021:3440305.
13. Li C, Li Z, Zhu M, Zhao T, Chen L, et al. (2012) Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis. PLOS ONE 7: e44764. doi:10.1371/journal.pone.0044764. PubMed: 23028610.
14. Zhang LQ, Wang J, Jiang F, Xu L, Liu FY, et al. (2012) Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLOS ONE 7: e34100. doi:10.1371/journal.pone.0034100. PubMed: 22457815.
15. Jamieson NB, Carter CR, McKay CJ, Oien KA, (2011) Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clin Cancer Res 17: 3316-3331. doi:10.1158/1078-0432.CCR-10-3284. PubMed: 21444679.
16. Stang A, (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-605. doi:10.1007/s10654-010-9491-z. PubMed: 20652370.
17. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR, (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16. doi:10.1186/1745-6215-8-16. PubMed: 17555582.
18. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826. doi:10.7326/0003-4819-127-9-199711010-00008. PubMed: 9382404.
19. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
20. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. doi:10.1002/sim.1186. PubMed: 12111919.
21. Bury J, Szumiło J, Da{ogonek}browski A, Ciechański A, Śliwińska J, et al. (2012) Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma. Pol Przegl Chir 84: 341-347. PubMed: 22935455.
22. Sun J, Jiao JR, Wei XQ, Zhao YG, Wu F, et al. (2008) Detection of serum survivin in gastric carcinoma patients and its clinical significance. Int J Dig Dis 28: 246-249.
23. Wang TM, Xu JM, Hu NZ, (2007) Expression of survivin, cyclooxygenase-2 and vascular endothelial growth factor and their prognostic significance in human gastric carcinoma. Chin J Clinical Gastroenterol 19: 35-39.
24. Yang QC, Feng YZ, Ji XH, Shen Y, (2006) Expression of survivin, caspase-3 in gastric carcinoma by using tissue microarray and its significance. China Oncology 16: 817-822.
25. Bertazza L, Mocellin S, Marchet A, Pilati P, Gabrieli J, et al. (2009) Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med 7: 111. doi:10.1186/1479-5876-7-111. PubMed: 20028510.
26. Chang JL, Chen TH, Wang CF, Chiang YH, Huang YL, et al. (2006) Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer. Exp Cell Res 312: 962-973. doi:10.1016/j.yexcr.2005.12.015. PubMed: 16427043.
27. Cheng P, Qin R, Zhang H, Wu JF, Wang DB, (2008) Expression of Survivin and Livin in gastric cancer and its clinical significance. World Chin J Digestology 16: 850-855.
28. Deng JY, Sun D, Liu XY, Pan Y, Liang H, (2010) STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol 16: 5380-5387. doi:10.3748/wjg.v16.i42.5380. PubMed: 21072904.
29. Lee GH, Joo YE, Koh YS, Chung IJ, Park YK, et al. (2006) Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur J Gastroenterol Hepatol 18: 957-963. doi:10.1097/01.meg.0000230086.83792.56. PubMed: 16894308.
30. Li Y, Tan BB, Fan LQ, Zhao Q, Liu Y, et al. (2010) Expression of COX-2, survivin in regional lymph node metastases of gastric carcinoma and the correlation with prognosis. Hepatogastroenterology 57: 1435-1441. PubMed: 21443099.
31. Meng JR, Tang HZ, Zhou KZ, Shen WH, Guo HY, (2012) TFF3 and survivin expressions associate with a lower survival rate in gastric cancer. Clin Exp Med. PubMed: 22996285.
32. Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, et al. (2004) Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients. Cancer Sci 95: 44-51. doi:10.1111/j.1349-7006.2004.tb03169.x. PubMed: 14720326.
33. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, et al. (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163: 109-116. doi:10.1016/S0304-3835(00)00677-7. PubMed: 11163114.
34. Song KY, Jung CK, Park WS, Park CH, (2009) Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn J Clin Oncol 39: 290-296. doi:10.1093/jjco/hyp020. PubMed: 19336448.
35. ChenSY, Wang QH, Liu TS (2005) The expression of survivin gene in gastric cancerous tissue and its relationship with gastric cancer prognosis. Chin J Dig 25: 280-283.
36. Sun YH, Wang XF, Qin XY, Wang CB, Lu SH, et al. (2003) Expression and clinical significance of survivin in gastric cancer. Chin J Gastrointest Surg 6: 191-194.
37. Yu JW, Jiang BJ, Ni XC, Wu JG, Li XQ, (2007) Combined evaluation of the clinical significance and prognosis of survivin and p53 expressions in gastric cancer. Int J Surg 34: 156-160.
38. Zhang JN, Liu Q, Lu W, (2007) Relationship between the expression of survivin and malignant proliferation of gastric carcinoma and the prognostic value of survivin. Pract J Cancer 22: 350-353.
39. Zou DM, Yang QX, (2009) The clinical significance in expression of Survivin and P53 in patients with gastric cancer. China Mod Doct 2: 30-31.
40. Vallböhmer D, Drebber U, Schneider PM, Baldus S, Bollschweiler E, et al. (2009) Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol 99: 409-413. doi:10.1002/jso.21271. PubMed: 19347901.
41. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, et al. (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584. doi:10.1038/25141. PubMed: 9859993.
42. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, et al. (1999) Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1: 461-466. doi:10.1038/70242. PubMed: 10587640.
43. Jacquemier J, Molès JP, Penault-Llorca F, Adélaide J, Torrente M, et al. (1994) p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer 69: 846-852. doi:10.1038/bjc.1994.164. PubMed: 7514027.